Safety and efficacy of a novel mini‐pool intravenous immunoglobulin therapy in children with primary immunodeficiency
MP-IVIG presented no safety issues and was as effective as STD-IVIG in IgG replacement in patients with PID. Due to the small numbers, the results have to be addressed with caution.
Authors
- Naglaa Samy Osman (ORCID: https://orcid.org/0000-0003-3599-3842)
- Mohamed Abou‐Elwafa Abdallah (ORCID: https://orcid.org/0000-0002-4624-4073)
- Madleen Adel A. Abdou
- Magdy El Ekiaby (ORCID: https://orcid.org/0000-0002-3881-1605)
- Eman NasrEldin (ORCID: https://orcid.org/0000-0003-3835-0471)
- Taghreed M. Kamal
- Abdelfattah Selim (ORCID: https://orcid.org/0000-0002-0211-2853)
- Maha M. Atwa
- Nada O. Abdelhameed
Institutions
- Assiut University (EG)
Publication Details
- Journal
- Vox Sanguinis
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1111/vox.13769
- Citations
- 2
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.48
Funders
- Assiut University